Update on MGD007 Trial – New Sites Open!

Please feel free to read, share your thoughts, your stories and connect with others!
User avatar
DK37
Posts: 510
Joined: Tue Sep 17, 2013 8:31 am
Location: San Diego

Update on MGD007 Trial – New Sites Open!

Postby DK37 » Mon Apr 27, 2015 12:02 pm

As many of you know, I am a big fan of the strategy employed by the experimental drug MGD007. It physically drags immune T-cells into close proximity to cancer cells displaying the gpA33 marker. About 95% of CRC (including CRC stem cells) are gpA33+. It is a brute force type of immunotherapy but unfortunately CRC has not responded to more subtle forms of immunotherapy (yet).

My main concern revolves around toxicity. Normal GI cells also display gpA33 – which could likely cause some GI-toxicity or colitis. A second part of my concern is like any strong immunotherapy, there is a chance of cytokine release syndrome (CRS) which can be very serious. https://en.wikipedia.org/wiki/Cytokine_release_syndrome Related to this, our own Belle was patient #1 on this trial and she experienced very bad toxicity (GI and potentially CRS as well). I have been told that of the 6 patients in dose cohort #1, only 1/6 patients developed such major tox (Belle). They are now dosing the next higher dose level. Until more patients get dosed, we can’t know if Belle was an extreme outlier in terms of tox or not – hopefully at least some of the next round of patients will blog their experiences on CC – both in terms of efficacy and tox.

The GI toxicity Belle had “may” have been an indirect measure that the drug was attacking her tumors as well? Sort of like the cetuximab rash/tumor efficacy correlation since in both cases, tox could be due to successfully hitting the target (EGFR+ or gpA33+) in a tissue outside the tumor, implying that the (EGFR+ or gpA33+) tumor is being hit too. For Belle’s tox reasons I remain cautious about this trial until we hear back how the next round of patients does but if I were later Stage IV, it would be in the top tier of trials I would be considering with my MD.

I mostly wanted to post this update today because they have dramatically increased the number of trial sites. This “could” indicate internal optimism that things are looking good. That potentially incorrect conjecture aside, having more sites open will generate data much faster (good or bad) which is great news for the patient community!

-DK

https://clinicaltrials.gov/ct2/show/NCT ... 007&rank=1

Current expanded sites pasted below:

United States, Maryland
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Recruiting
Baltimore, Maryland, United States, 21205
Contact: Ellen Lilly-Foreman, RN, OCN 443-287-4961 lillyel@jhmi.edu
Contact: Thomas Brown 410-502-5328 tbrown55@jhmi.edu
Principal Investigator: Daniel Laheru, MD

United States, Massachusetts
Dana Farber Cancer Institute Recruiting
Boston, Massachusetts, United States, 02215
Contact: Margaret Carey 617-632-5575 MargaretM_Carey@DFCI.HARVARD.EDU
Principal Investigator: David P Ryan, MD

Massachusetts General Hospital Recruiting
Boston, Massachusetts, United States, 02114
Contact: Susan Sheehan, RN 617-724-4000 Ssheehan1@mgh.harvard.edu
Principal Investigator: David P Ryan, MD

United States, North Carolina
Duke University Medical Center Recruiting
Durham, North Carolina, United States, 27710
Contact: Anthony Amara 919-668-1861 anthony.amara@dm.duke.edu.......
Principal Investigator: Herbert Hurwitz, MD

Carolina Biooncology Institute Recruiting
Huntersville, North Carolina, United States, 28078
Contact: Ashley McClain 704-947-6599 ext 117 amcclain@carolinabiooncology.org
Principal Investigator: John Powderly, MD

United States, Oregon
Providence Portland Medical Center Recruiting
Portland, Oregon, United States, 97213
Contact: Yue-yun To, RN 503-215-2855 yue-yun.to@providence.org.......
Principal Investigator: Todd Crocenzi, MD
Last edited by DK37 on Mon Apr 27, 2015 12:59 pm, edited 1 time in total.
6/4/2012 Dx Stage 3C CRC @ 40 yo. MSS, KRAS-WT, BRAF-WT, p53-mut
7/12 FOLFOX/FOLFIRI
2/13 NED!
8/13 Enlarged lymphs - Stable
10/14 Stage IV. Lung & Lymph mets. 5-FU+bev
3/15 Cetuximab
11/15 FOLFIRI + bev
11/16 Signs of FOLFIRI resistance (Lymph mets)
1/17 Palliative radiation for resistant mets
2/17 FOLFIRI + bev + Maraviroc (off-label)
3/17 FOLFIRI + Erbitux + Maraviroc (off-label)
MSS-CRC Clinical Trial Finder: http://trialfinder.fightcrc.org/
2016 Colondar 2.0 Model
DK37 Science Posts List

User avatar
vilca11
Posts: 730
Joined: Fri Feb 14, 2014 11:19 am
Location: Moscow, Russia; Baltimore, USA 1992; Vilcabamba, Ecuador 2012

Re: Update on MGD007 Trial – New Sites Open!

Postby vilca11 » Mon Apr 27, 2015 12:39 pm

Thanks for posting, DK! In the absence of Maia, we would be in the dark without you and Joe777777, very important to know what to keep an eye on and try to hang in until the most promising thing is available for so many of us. Your input is especially priceless, since you are an industry insider and can "feel" anything new that pups up incomparably much better than anyone else....So, again, many thanks for your input/contributions to this forum, dear DK!
11/2005 CC stage 1, F,50yo@dx
Mod dif adenocar, MSS, APC, TP53, CEAs1.6-4.8
1/12 1met liver@Vena Cava, RFA, 3oxi,11 5FU
8/13 2 mets same place,SBRT
4/14 2 Xeliri+Avastin
5/14 Nano Knife liver same 2 mets
6/14 2 Xeliri, ADAPT
4/15 PET, 2 same mets,Cryo Liver
5/15 MJ Oil, Herbs, Suppl, ADAPT
10/15 PET, same area, doubled in size, high SUV
10/15 RH, HAI, visceral involv., no LN
2/16 red FF, 50% red dose FUDR, CEA trends up
3/16 CT, PET, MRI L.Lobe all in small tumors
4/16 No acceptable options, going home

pukalania
Posts: 454
Joined: Mon Aug 06, 2012 2:54 am
Location: Honolulu, Seattle

Re: Update on MGD007 Trial – New Sites Open!

Postby pukalania » Mon Apr 27, 2015 12:45 pm

Thank you DK for posting this :)
wife 34 dx DH stage IV
Feb10 col res
May10 12 x FOLFOX
Aug12 tumor in sig colon,mets in liver
Aug12 Xeliri Ava
Oct12 xel celebrx rad
Feb13 liver/colon res
Sep13 ill reversal, fistula,
Folfiri SBRT,ADAPT ava
Apr 15 continued growth liver and lungs

User avatar
bitchslapped
Posts: 1468
Joined: Tue Sep 09, 2014 3:23 pm
Location: PNW/USA

Re: Update on MGD007 Trial – New Sites Open!

Postby bitchslapped » Mon Apr 27, 2015 12:53 pm

Yes, thanks for updating, especially posting the effects Belle experienced as some may not be aware.
DSS,35YO,unresect mCRC DX 7/'14,lvr,LN,peri,rib
FOLFOX+Avstn 4 Rnds d/c 10/'14
Stent 9/'14
FOLFIRI+Avstn 10/'14
Gone From My Sight 2/20/15
Me:garden variety polyps + precancerous polyp
Carergver x2 DH,DM dbl occupancy,'03-'10
DH dx 47YO mCRC,'04-'07 fried x HAI
DM dx CC 85YO,CC,CHF,stroke,dementia,aphasia

lpas
Posts: 1001
Joined: Wed Nov 19, 2014 11:11 pm

Re: Update on MGD007 Trial – New Sites Open!

Postby lpas » Mon Apr 27, 2015 2:05 pm

Thanks so much, DK. What concerns me about Belle's experience is that, in addition to the horrible side effects, it didn't seem as though she benefited much from the treatment. Have you heard if any of the other first 6 patients showed any improvement (or at least a halt in progression)?

As an FYI, it looks like Colondar model and occasional poster, Lindsey Motley, is also attempting this trial. Some may remember that Lindsey was diagnosed at age 26, while 17 weeks pregnant. See her discussion here on Caring Bridge:

http://www.caringbridge.org/visit/lindseymotley
11/14 Dx sigmoid CC @ 45yo
12/14 Colectomy + hysterectomy
Stage IIIB, T3N1bM0, 2/20 nodes, MSS, G2, KRAS(A146T), TP53, SMAD4, ERBB2, CEA 1.0
2/15-7/15 XELOX & Celebrex
3/16 Ovarian mass removed. Benign fibroid
9/16 clean scope
4/18 clean CT
Ongoing Celebrex, Tagamet & other carefully-targeted supplements
Post-chemo CEA 3.0, 2.5, 2.3, 2.0, 1.6, 1.3, 1.8, 2.1, 1.8, 2.0, 1.8, 1.9, 1.7, 1.5, 1.6, 1.5, 1.4, 1.4, 1.3, 1.3, 1.6, 1.6, 1.3, 1.4, 1.6, 2.2, 2.4
Mom to a 4 & 6yo

janderson
Posts: 679
Joined: Tue Mar 27, 2012 11:46 am

Re: Update on MGD007 Trial – New Sites Open!

Postby janderson » Mon Apr 27, 2015 4:47 pm

Thank you so much for posting and giving your scientific insight.
DX 10-05 stage IV
liver resection 12-05 Folfox1-05 to 7-06
Liver resection 8-07 Folfiri 9-07 to 3-08
Liver resection 12-11
Recurrence 2/7/2014, liver, chestwall mets, 16 rounds chemo
7/3/14, y90 radioembolization, steady shrinkage
12/8/14, cryoablation to liver and chest wall
6/1 to 6/26 SBRT radio surgery
7/2 more cryo ablation to right lung
7/16 lung infection drain tube installed
9/4 chest wall resection to remove 2 ribs

User avatar
peanut_8
Posts: 2260
Joined: Sun May 25, 2014 1:31 pm
Location: Capital of Texas

Re: Update on MGD007 Trial – New Sites Open!

Postby peanut_8 » Mon Apr 27, 2015 4:56 pm

Thanks so much for posting and keeping us educated, DK.

We are truly lucky to have you.

peanut
Terri aka peanut
diagnosed Jan 14, RC stage 2a, age 56
permanent colostomy
MSS
April 14, 28 chemo/rad with Xeloda
June 14 adjuvant Xeloda 6 rounds
currently NED

User avatar
DK37
Posts: 510
Joined: Tue Sep 17, 2013 8:31 am
Location: San Diego

Re: Update on MGD007 Trial – New Sites Open!

Postby DK37 » Mon Apr 27, 2015 5:43 pm

lpas wrote:Thanks so much, DK. What concerns me about Belle's experience is that, in addition to the horrible side effects, it didn't seem as though she benefited much from the treatment. Have you heard if any of the other first 6 patients showed any improvement (or at least a halt in progression)?

As an FYI, it looks like Colondar model and occasional poster, Lindsey Motley, is also attempting this trial. Some may remember that Lindsey was diagnosed at age 26, while 17 weeks pregnant. See her discussion here on Caring Bridge:

http://www.caringbridge.org/visit/lindseymotley


Hi lpas,

Please correct me if my memory is faulty but my recollection is that Belle did not have too many infusions because her side effects/toxicity were so bad she had to stop the trial. I don't remember her disclosing any scan results, but once again my memory may be wrong. Regardless, if she did only get a small number of infusions at the lowest first dose tested, it is probably too early to judge the potential efficacy of the drug based upon her experience.

This is especially true in regards to immunotherapies, which often require longer dosing to see efficacy on scans than is normally seen in older chemo/targeted therapy type regimens. I believe in some of the earliest checkpoint inhibitor trials they realized that they missed out on noticing some efficacy if they initially relied on the first scan to make a preliminary judgment, efficacy sometimes only became clear later on in the next set of scans. Immunotherapies can also sometimes show "pseudo progression" on first scans due to infiltration of immune cells into the tumor making the tumors appear to get larger. Aside from lower tox, I have not heard word on efficacy in the other 5 first cohort patients - either good news or bad news,

Purely from a "scientific guess" perspective, I like MGD007 because it is a logical approach and because there is successful proof of principle (in humans!) of the same strategy being used by Amgen's FDA-approved drug "Blincyto" against the "ALL" blood cancer. Blincyto uses a different cell marker in order to drive T-cells toward the "ALL" cell type, but strategically they use the same process as MGD007, MGD007 just switches to a CRC cell marker "gpA33". Because of that, as a scientific guess, I think MGD007 has a great chance of efficacy (better than usual) - ***IF*** on-target toxicity allows them to dose high enough/long enough, since normal GI cells also have the gpA33 marker. So in the end, I am most worried about toxicity screwing up MGD007's chances. I assume there will probably be GI tox which will need to be managed well & long enough to allow the drug to do its job & eradicate the tumor.

Hope that makes sense - but all of this is just my personal guesses at this point. I'm waiting for clinical data like everyone else. Yes, it sounds like Lindsey Motley may be blogging her MGD007 experiences shortly - that could be very useful information for all of us to read. She is an AMAZING woman - I sincerely hope the trial works for her!!

-DK
6/4/2012 Dx Stage 3C CRC @ 40 yo. MSS, KRAS-WT, BRAF-WT, p53-mut
7/12 FOLFOX/FOLFIRI
2/13 NED!
8/13 Enlarged lymphs - Stable
10/14 Stage IV. Lung & Lymph mets. 5-FU+bev
3/15 Cetuximab
11/15 FOLFIRI + bev
11/16 Signs of FOLFIRI resistance (Lymph mets)
1/17 Palliative radiation for resistant mets
2/17 FOLFIRI + bev + Maraviroc (off-label)
3/17 FOLFIRI + Erbitux + Maraviroc (off-label)
MSS-CRC Clinical Trial Finder: http://trialfinder.fightcrc.org/
2016 Colondar 2.0 Model
DK37 Science Posts List

User avatar
jgall
Posts: 814
Joined: Wed Jan 05, 2011 9:44 pm
Location: New York City

Re: Update on MGD007 Trial – New Sites Open!

Postby jgall » Mon Apr 27, 2015 8:50 pm

And my DH had a good call with the trial people at one of the new sites, so I think he may also be jumping on this trial in the near future. I will definitely post his experiences here as well as our caringbridge when we get there. Thanks for your help, DK, in assisting us over the last couple months. You've been our angel and we can't thank you enough.

Julia
DH Chris, 50, Dx Nov '10 Stg 4
cardiac arrest from 5-FU
Iri/Erbi, RFA, liver/colon resection, more Iri/Erbi
Oct14-Feb15 clinical trial
SIRT Apr15-unsuccessful
Stopped treatment May15
Hospice July15
Passed 8/15/15
http://www.caringbridge.org/visit/chrisandjulia

lpas
Posts: 1001
Joined: Wed Nov 19, 2014 11:11 pm

Re: Update on MGD007 Trial – New Sites Open!

Postby lpas » Mon Apr 27, 2015 9:06 pm

Thanks, DK. That explanation makes a lot of sense. Here's hoping the toxicities can be managed and we see some good results for this next round. And an extra special thanks for keeping us so well-informed (as always!).

Good luck to you too, Julia and Chris. Will be swinging lots of chickens for you!
11/14 Dx sigmoid CC @ 45yo
12/14 Colectomy + hysterectomy
Stage IIIB, T3N1bM0, 2/20 nodes, MSS, G2, KRAS(A146T), TP53, SMAD4, ERBB2, CEA 1.0
2/15-7/15 XELOX & Celebrex
3/16 Ovarian mass removed. Benign fibroid
9/16 clean scope
4/18 clean CT
Ongoing Celebrex, Tagamet & other carefully-targeted supplements
Post-chemo CEA 3.0, 2.5, 2.3, 2.0, 1.6, 1.3, 1.8, 2.1, 1.8, 2.0, 1.8, 1.9, 1.7, 1.5, 1.6, 1.5, 1.4, 1.4, 1.3, 1.3, 1.6, 1.6, 1.3, 1.4, 1.6, 2.2, 2.4
Mom to a 4 & 6yo

User avatar
DK37
Posts: 510
Joined: Tue Sep 17, 2013 8:31 am
Location: San Diego

Re: Update on MGD007 Trial – New Sites Open!

Postby DK37 » Mon Apr 27, 2015 11:48 pm

I'm happy to help give a "research scientist's" viewpoint, so that fellow patients can have better informed medical decision discussions with their MD's. I sometimes joke that CC feels like Gilligan's Island and I've been cast as the Professor haha.

But in all seriousness, I too am only making best guesses based upon pre-clinical data and logic - with these early trial drugs, at the end of the day no one has a crystal ball, the trial will tell the data. As of right now, MGD007 showed very serious tox (Belle) in 1/6 = 17% of patients. That is the data currently known. Everything else is just high efficacy in animal models, a strong logical basis and a proof of principle of the strategy in a different type of cancer as our current guiding lights. I am so grateful to trial participants like Belle, Lindsey, Chris & many others in the CC who trail blaze for the rest of us... All incredible heroes in my book.

-DK
6/4/2012 Dx Stage 3C CRC @ 40 yo. MSS, KRAS-WT, BRAF-WT, p53-mut
7/12 FOLFOX/FOLFIRI
2/13 NED!
8/13 Enlarged lymphs - Stable
10/14 Stage IV. Lung & Lymph mets. 5-FU+bev
3/15 Cetuximab
11/15 FOLFIRI + bev
11/16 Signs of FOLFIRI resistance (Lymph mets)
1/17 Palliative radiation for resistant mets
2/17 FOLFIRI + bev + Maraviroc (off-label)
3/17 FOLFIRI + Erbitux + Maraviroc (off-label)
MSS-CRC Clinical Trial Finder: http://trialfinder.fightcrc.org/
2016 Colondar 2.0 Model
DK37 Science Posts List

User avatar
lilacbreastedroller
Posts: 90
Joined: Thu Sep 05, 2013 10:25 am

Re: Update on MGD007 Trial – New Sites Open!

Postby lilacbreastedroller » Tue Apr 28, 2015 7:24 am

NIfty. They ought to invent some kind of special probiotic yogurt patients can eat that would coat the inside of the colon and protect it, if that would even work since the yogurt would be digested in the stomach... There needs to be something that wouldn't protect the cancer cells, only the healthy ones. My vote is something benign, ingestible, and strawberry flavored!

- Karin
dx 6/1/12@45yo
RT, 4 liv, 5 lung
7/12 FOLFOX
2/13 Xeloda 4k mg/d
7/13 DC VAX,1k mg/d metro Xel
11/13 Erbi, Irino
6/14 clinical trial lirilumab, nivolumab
9/14 Stivarga
1/15 clinical trial immunotherapy (young TILs)
RT, mets to liv, lung, adrenal, lns

gator.girl
Posts: 37
Joined: Thu Sep 05, 2013 1:05 pm

Re: Update on MGD007 Trial – New Sites Open!

Postby gator.girl » Tue Apr 28, 2015 12:03 pm

Thanks DK! My docs all think I am so smart but it's all because of you lol!!!
Maybe I should start a new thread but was wondering what you thought of the new approved drug ramucirumab to use with folfiri

http://www.drugs.com/newdrugs/fda-appro ... -4206.html

Not sure how to tag people here in cc? So I thought I'd put here since you seem to follow this thread... But am happy to start a new thread...


Thanks

Ginger from Gilligan's island lol :D
Dx 8/13 @ 40
Stage IV - innumerable mets to liver
12 rounds of Folfox + Avastin
8 months on maintenance
11/14 Y90 to right side of liver
01/15 Gallbladder removal and colon resection
02/15 Mets to lungs
Now on Folfiri

skypup
Posts: 2598
Joined: Mon Dec 17, 2012 12:12 pm

Re: Update on MGD007 Trial – New Sites Open!

Postby skypup » Tue Apr 28, 2015 12:13 pm

I claim Gilligan! :D

User avatar
DK37
Posts: 510
Joined: Tue Sep 17, 2013 8:31 am
Location: San Diego

Re: Update on MGD007 Trial – New Sites Open!

Postby DK37 » Wed Apr 29, 2015 12:10 am

gator.girl wrote:was wondering what you thought of the new approved drug ramucirumab to use with folfiri

http://www.drugs.com/newdrugs/fda-appro ... -4206.html

D


Hi Gator.girl - To my eyes it is an incremental advance rather than a major breakthrough - but incremental advances do slowly add up... Nice to have one more approved therapy to try in the arsenal until the inevitable breakthroughs do arrive :) Works similarly in KRAS-wt and KRAS-mut, similar class of drug as Avastin.

-DK
6/4/2012 Dx Stage 3C CRC @ 40 yo. MSS, KRAS-WT, BRAF-WT, p53-mut
7/12 FOLFOX/FOLFIRI
2/13 NED!
8/13 Enlarged lymphs - Stable
10/14 Stage IV. Lung & Lymph mets. 5-FU+bev
3/15 Cetuximab
11/15 FOLFIRI + bev
11/16 Signs of FOLFIRI resistance (Lymph mets)
1/17 Palliative radiation for resistant mets
2/17 FOLFIRI + bev + Maraviroc (off-label)
3/17 FOLFIRI + Erbitux + Maraviroc (off-label)
MSS-CRC Clinical Trial Finder: http://trialfinder.fightcrc.org/
2016 Colondar 2.0 Model
DK37 Science Posts List


Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”



Who is online

Users browsing this forum: Fluff Bottom, Google [Bot] and 30 guests